Back to Search
Start Over
Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer
- Source :
- Journal of Cancer Research and Clinical Oncology. 146:2979-2988
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- Dissociated response (DR, reduction at baseline or increase
- Subjects :
- Adult
Male
0301 basic medicine
Oncology
Target lesion
Cancer Research
medicine.medical_specialty
Lung Neoplasms
medicine.medical_treatment
Disease
03 medical and health sciences
Antineoplastic Agents, Immunological
0302 clinical medicine
Carcinoma, Non-Small-Cell Lung
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
Humans
Medicine
Lung cancer
Aged
Retrospective Studies
Hematology
business.industry
General Medicine
Immunotherapy
Middle Aged
medicine.disease
030104 developmental biology
Response Evaluation Criteria in Solid Tumors
030220 oncology & carcinogenesis
Propensity score matching
Cohort
Disease Progression
Female
business
Subjects
Details
- ISSN :
- 14321335 and 01715216
- Volume :
- 146
- Database :
- OpenAIRE
- Journal :
- Journal of Cancer Research and Clinical Oncology
- Accession number :
- edsair.doi.dedup.....c3975414976212048197a873fcc0835c
- Full Text :
- https://doi.org/10.1007/s00432-020-03282-y